Search results
ASCO 2024: Alligator shares positive data for pancreatic cancer drug
Pharmaceutical Technology via Yahoo Finance· 17 hours agoThe Sweden-headquartered company presented the Phase II readout at the American Society of Clinical...
GSK’s Jemperli shows potential in Phase II trial for locally advanced rectal cancer
Clinical Trials Arena via Yahoo Finance· 23 hours agoUK-based pharmaceutical company GSK has reported updated results from a Phase II study of Jemperli...
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating...
Benzinga· 2 days agoCET – Transgene TNG, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer today announces that the first patient has been enrolled in the
Everything New in the Genshin Impact Version 4.7 update
ClutchPoints· 2 hours agoGenshin Impact Version 4.7 is now live bringing three new characters, a continuation to the Archon...
Genmab and BioNTech report data from Phase II GCT1046-04 trial for mNSCLC
Clinical Trials Arena via Yahoo Finance· 2 days agoGenmab and BioNTech announced the initial data from the phase II GCT1046-04 trial, which evaluated...
Angle PLC Announces Preliminary Results
Digital Journal· 2 hours agoGUILDFORD, SURREY / ACCESSWIRE / June 5, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for ...
Biohaven doses first subject in Phase I/II tumour treatment study
Clinical Trials Arena via Yahoo Finance· 6 days agoIt is a first-in-human, multi-centre, open-label trial structured into two segments: a Phase I dose...
APAC leads in clinical trials for asthma during 2019-2023
Clinical Trials Arena via Yahoo Finance· 24 hours agoPhase I trials comprised 42.4% of the total clinical trials. This was followed by Phase II (21.4%), ...
Constantiam Biosciences Nabs $2.05M Phase II SBIR Grant From NHGRI
GenomeWeb News· 19 hours agoBioinformatic analysis startup Constantiam Biosciences said on Monday that it has been awarded a $2.05 million Phase II Small Business Innovation Research ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoGenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor ...
